Supporting Evidence

Join The Conversation! | https://trialsitenews.com/ Trial Site News recently were able to review leaked internal emails from the European Medicines Agency (EMA) and meeting report between the agency and Pfizer. The EMA oversees the evaluation and supervision of medicinal products for the European Union. Like other regulatory health bodies, its main responsibility is to protect and promote public health. Snapshots of internal EMA email correspondence; a November 26, 2020, PowerPoint presentation from a pivotal meeting between Pfizer and the agency, as well as a confidential 43-page Pfizer report were provided by an anonymous source because of their trust in Trial Site’s commitment to transparency, accessibility, and accountability in furtherance of a highly ethical, quality-focused and public health-centric biomedical research industry. Article Link | https://www.trialsitenews.com/a/what-the-leaked-ema-emails-docs-reveal-major-concerns-with-pfizer-c-19-vaccine-batch-integrity-and-the-race-to-authorise-cdda0ba2

Peter Doshi and colleagues' heroic attempt at re-analysis of the Phase 3 trials

Was it fraud? You tell me.

(Washington, D.C.) Judicial Watch announced today that it received 254 pages of records from the Department of Health and Human Services (HHS) this included emails of then-Director of the National Institutes of Health (NIH) Francis Collins regarding a British group’s recommendations on the use of Ivermectin to prevent and treat COVID-19.

Judicial Watch received 466 pages of records from the Department of Health and Human Services (HHS) regarding biodistribution studies and related data for the COVID-19 vaccines that show a key component of the vaccines developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection site, mainly the liver, adrenal glands, spleen and ovaries of test animals, eight to 48 hours after injection.

TrialSite has learned of material information regarding mRNA vaccine safety revealed by a freedom of information act (FOIA) request filed by a group of Canadian physicians. These doctors have become concerned about COVID-19 mRNA vaccine safety. This new safety information involves the Pfizer mRNA-based vaccine known as BNT162b2 or “Comirnaty.” The FOIA documents reveal animal study results demonstrating that the Pfizer mRNA-based vaccine does not remain at the injection site, but rather appears to spread widely after injection. According to the documents, pre-clinical studies show that the active part of the vaccine (mRNA-lipid nanoparticles), which produce the spike protein, spreads throughout the body and is then concentrated in various organs, including the ovaries and spleen. The FOIA-produced data sets are incomplete, so the full meaning of these data cannot be determined at this time. TrialSite has also learned via regulatory documents that apparently (at least in their European Medicines Agency submission), Pfizer did not follow industry-standard quality management practices during preclinical toxicology studies during vaccines, as key studies did not meet good laboratory practice (GLP). The full panel of industry-standard reproductive toxicity and genotoxicity studies were apparently also not performed. But does this matter in light of the risk-benefit analysis associated with regulatory emergency use authorization (EUA)?

Evidence of fraud within the regulatory system?

Alexandra Latypova ("Sasha") is a retired pharmaceutical industry executive and entrepreneur. She holds an MBA degree from Dartmouth College and spent approximately 25 years in pharmaceutical research

It is not normal for young athletes to suffer cardiac arrest or death while playing sport, but most of these come shortly after a COVID shot.

Researchers at Charité Berlin, Germany’s top hospital and one of Europe’s largest, announced a high rate of COVID-19 vaccine severe side effects lasting months or longer based on a survey of about 40,000 Germans.

Serious AE's in 1 out of every 125 vaccinated; 40x underreporting factor for severe adverse events; government urged to take vaccine injury seriously, find solutions

Comprehensive investigation and analysis by Mathew Crawford

The Vaccine Wars Part XXXIII

They missed hundreds of serious adverse events that are more elevated than myocarditis. A new VAERS analysis done by Albert Benavides blows the doors off the "safe and effective" narrative.

The DMED data exposed by attorney Tom Renz and Senator Johnson is a smoking gun. General Austin should order all military docs to speak the truth. But he isn't. Why not?

An independent derivation of the VAERS URF using the CMS death data leads to a URF of 44.64 which then leads to a 388K excess death estimate.

They never found any safety signals, because they didn't look for them

By Maryanne Demasi, PhD

Vaccine manufacturers, like the rest of the public, must submit a FOIA to the FDA to obtain additional information regarding serious adverse events, including deaths, submitted to VAERS. The problem: they are not doing it.

Flawed reporting system doesn't measure scale of the proble

My attention was drawn by a good friend in Australia today to this pre-print article by the NCIRS, who are a major contributor to the NSW COVID vaccine surveillance reports (although their presence has become less obvious than it was in this November report espousing the “real world effectiveness” of the COVID vaccines conveniently just before the “boosters” were to be rolled out).

Are hospitals conspiring to gin up COVID-19 deaths to make the pandemic look worse than it is? No. There’s a simpler explanation: incentives. As Minnesota lawmaker and longtime family practitioner Dr. Scott Jensen recently observed, hospitals are incentivized to pressure physicians to include COVID-19 on death certificates and discharge papers, since the CARES Act increases Medicare payments to hospitals treating COVID-19 victims.

null

“Data was very easily used by influencers and decision-makers to fit particular narratives,” Norman Fenton, Ph.D., a mathematician at Queen Mary University of London, said in an interview on “RFK Jr. The Defender Podcast.”